Strata Critical Medical, Inc. (SRTA)

Strata Critical Medical Stock Forecast

Stock Price Forecast

According to 4 analysts polled by S&P Global, Strata Critical Medical stock has a consensus rating of "Strong Buy" and an average price target of $8.88. The average 1-year stock price forecast is 65.36% higher than the current stock price, while the lowest is $8.00 (+48.98%) and the highest is $11.5 (+114.15%).

Price Target: $8.88 (+65.36%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$8.00	$8.88	$8.00	$11.5
Change	+48.98%	+65.36%	+48.98%	+114.15%

* Price targets were last updated on Mar 25, 2026.

Analyst Ratings

The average analyst rating for Strata Critical Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	2	2	4	4	4
Buy	0	0	0	0	0
Hold	0	0	0	0	0
Sell	0	0	0	0	0
Strong Sell	0	0	0	0	0
Total	2	2	4	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Bill Bonello Craig-Hallum	Craig-Hallum	Strong Buy Initiates $8	Strong Buy	Initiates	$8	+48.98%	Mar 25, 2026
Yuan Zhi B. Riley Securities	B. Riley Securities	Strong Buy Initiates $8	Strong Buy	Initiates	$8	+48.98%	Mar 25, 2026
Benjamin Haynor Lake Street	Lake Street	Strong Buy Initiates $8	Strong Buy	Initiates	$8	+48.98%	Dec 2, 2025
Ben Klieve Lake Street	Lake Street	Strong Buy Maintains $6.5 → $7.25	Strong Buy	Maintains	$6.5 → $7.25	+35.01%	Sep 17, 2025

Financial Forecast

Revenue This Year

274.56M

Increased by 39.27%

from 197.14M

Revenue Next Year

297.94M

Increased by 8.52%

from 274.56M

EPS This Year

-0.10

from 0.50

EPS Next Year

-0.01

from -0.10

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	67.16M	146.12M	225.18M	146.82M	197.14M	274.56M	297.94M
Revenue Growth	32.92%	117.58%	54.11%	-34.80%	34.28%	39.27%	8.52%
EPS	-0.68	-0.38	-0.76	-0.35	0.50	-0.10	-0.01
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	6	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029
High	284.0M	308.5M
Avg	274.6M	297.9M
Low	262.7M	283.2M

Revenue Growth

Revenue Growth	2026	2027	2028	2029
High	44.1%	12.4%
Avg	39.3%	8.5%
Low	33.3%	3.2%

EPS Forecast

EPS	2026	2027
High	-0.07	-0.01
Avg	-0.10	-0.01
Low	-0.14	-0.01

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.